Current Edition

Advancing Heart Failure Research Through Innovative Clinical Trial Design

Cardiovascular disease remains public enemy number one in healthcare. Taking the top spot on the mortality scale, diseases of the heart are predicted to affect nearly 10 million people over the age of 18 by 2020 – a 25 per cent increase in just a decade. Karen Hill and Nancy Newark of Worldwide explore the many factors contributing to limited advances in heart failure discovery and treatment.